# Jill P. Buyon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jill-p-buyon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,371 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 102 |
| i10-index | 335 |
| Last Known Institution | NYU Langone Health |
| OpenAlex ID | https://openalex.org/A5072473587 |
| ORCID iD | https://orcid.org/0000-0002-3852-7129 |
| Works | 575 |

## Researcher papers

Showing 12 of 13.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [The immune cell landscape in kidneys of patients with lupus nephritis](https://scholariq.org/papers/the-immune-cell-landscape-in-kidneys-of-patients-with-lupus-nephritis/)
- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [Predictors of Pregnancy Outcomes in Patients With Lupus](https://scholariq.org/papers/predictors-of-pregnancy-outcomes-in-patients-with-lupus/)
- [Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus](https://scholariq.org/papers/maternal-use-of-hydroxychloroquine-is-associated-with-a-reduced-risk-of/)
- [Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies](https://scholariq.org/papers/prediction-of-adverse-pregnancy-outcome-by-the-presence-of-lupus-anticoagulant/)
- [Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus](https://scholariq.org/papers/maternal-and-fetal-factors-associated-with-mortality-and-morbidity-in-a-multi/)
- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of-2/)
- [Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block](https://scholariq.org/papers/utility-of-cardiac-monitoring-in-fetuses-at-risk-for-congenital-heart-block/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cell Adhesion Molecules Research](https://scholariq.org/topics/cell-adhesion-molecules-research/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research-2/)
- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)

## Researcher university

- [NYU Langone Health](https://scholariq.org/institutions/nyu-langone-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.